arly human B cell development occurs in the bone marrow (BM) 3 as hemopoietic stem cells (HSC) develop via various B lineage-restricted precursors into immature B (IM-B) cells, which then leave the BM and enter the periphery. The different stages can be identified by the expression of CD Ags and the rearrangement status of Ig H and L chains, and the current consensus is that B lineage-committed cells pass through a CD34 ϩ CD10 ϩ CD19 Ϫ common lymphoid progenitors (CLP) early B (E-B) stage before they mature via CD34 ϩ CD19 ϩ CD10 ϩ pro-B, CD34 Ϫ CD19 ϩ large pre-B I and II, and CD34 Ϫ CD19 ϩ small pre-B II into CD34 Ϫ CD19 ϩ sIgM ϩ IM-B cells (1, 2) . Galy et al. (3) were the first to identify human CLP by demonstrating that CD34 high Lin Ϫ CD10 ϩ cells had B, T, NK, and dendritic cell potential. Later studies have indicated that this population is biased toward B lineage development and termed the population E-B cells (4, 5) . Rearrangements of the VDJ H chain locus are characteristic of pro-B cells and require the expression of the lymphocyte-specific recombination enzymes RAG1, RAG2, and TdT (6) . The expression of pre-BCR, composed of IgH chains and surrogate L chains (VpreB and 14.1), is a hallmark for the pre-B cell population. Signaling through pre-BCR promotes L chain (VJ L ) rearrangement and allelic exclusion at the Ig H chain locus. Once VJ L rearrangements are successful, L chains are expressed and combine with H chains as well as Ig␣/Ig␤ to form a functional BCR expressed on IM-B cells.
Early B cell development is controlled by a hierarchical regulatory network of transcription factors including PU.1, E2A, EBF, and Pax5 (7) . E2A and EBF are required for the initiation of E-B cell development by regulating the expression of B lineage-specific genes, including PAX5, which is essential for B cell commitment maintenance (8, 9) . Furthermore, development of lymphoid cells is supported by cytokines and interactions with stromal cells, as demonstrated by in vitro studies of human B cell development (10) .
Genome-wide gene expression profiling has been performed in murine precursor B cells (11, 12) . Recently, van Zelm et al. (13) investigated the Ig gene rearrangement steps in correlation to the transcription factor expression of developing B cells from the BM of healthy children. However, whereas the later stages of human B lineage development are well-characterized, the transitions from HSC into B lineage-committed cells have been explored in less detail. The aim of this study was to characterize the earliest steps of human B cell development in adult BM by gene expression profiling. Total RNA was extracted from HSC, E-B, pro-B, pre-B, and IM-B cell populations from human BM, amplified, and hybridized to Lymphochip cDNA microarrays. Altogether, this study provides new insight into the molecular processes that take place in early human B cell differentiation.
Hospital. CD34
ϩ or CD10 ϩ cells were isolated from BM by the use of immunomagnetic beads (CD34 Dynabeads, or sheep anti-mouse IgGcoated Dynabeads labeled with anti-CD10 mAb; Invitrogen Life Technologies) as previously described (14, 15) . CD38 Ϫ CD34 ϩ HSC and CD38 ϩ CD34 ϩ CD10 ϩ CD19 Ϫ E-B cells were obtained by FACS sorting on a FACSDiVa cell sorter (BD Biosciences) after labeling of CD34 ϩ BM cells with anti-CD38 FITC, anti-CD34 allophycocyanin, anti-CD10 PECy7, and anti-CD19 PECy5.
cells were obtained by FACS sorting after labeling of CD10
ϩ BM cells with anti-CD10 PECy7, anti-CD19 PECy5, anti-IgM FITC, and anti-CD34 allophycocyanin (details in Table I ). All cell populations were collected in 5-ml tubes, washed once in PBS, and subjected to RNA isolation. Detection of intracellular proteins was performed after labeling CD34 ϩ BM cells with Abs used to identify the various subpopulations, followed by fixation and permeabilization and subsequent staining with Abs (anti-Bcl-2, antimyeloperoxidase (MPO), anti-J chain, or anti-TdT; Table I ). The labeled cells were analyzed in LSR II (BD Biosciences) using FlowJo software (www.flowjo.com).
RNA extraction, amplification, labeling, and hybridization
Each cell population was isolated from six donors and analyzed independently. Total RNA was extracted from 1 ϫ 10 4 -8 ϫ 10 4 cells by the RNA Microprep kit (Stratagene), and subjected to two cycles of in vitro transcription according to a slightly modified protocol from Baugh et al. (16) , previously described by Nygaard et al. (17) . The quality of the aRNA was evaluated by the Agilent 2100 Bioanalyzer. The gene expression profiling was performed using the Lymphochip cDNA microarrays, and the analysis was performed as previously described (18) . Data files for all experiments can be found at www.lymphochip.nih.xx.
Statistical analysis
Genes with Ͼ30% missing values were removed from the data set. The remaining missing values were estimated and imputed with LSimpute_ adaptive (19) . Subsequently, each gene expression profile was mean centered. These steps were performed using J-Express software (Molmine) (20) . Mean expression profiles from spots representing the same sequence accession number were joined by calculating the mean log ratio of these spots. All subsequent analysis was based on these mean expression profiles. Genes displaying differential expression between populations were detected using a two sample t test with pooled variance estimate. Genes were sorted after significance, and the significance threshold was selected so that the false discovery rate (FDR) for the reported genes was 10%. Finally, only genes with at least a 2-fold change between stages were kept. Hierarchical cluster analysis was performed by cluster and the results were visualized by TreeView (21) . The expression level of each gene was relative to its median expression level across all samples. The proliferation signature was developed by Staudt and colleagues (18) . The other gene sets are based on information from Gene Ontology (GO; http://source.stanford.edu/cgi-bin/source/sourceSearch). The GO was used to select, within the significant probe sets, for probe sets annotated with GO terms representing genes associated with the variable lineages B, T, NK, dendritic cell, and myeloid, or genes associated with apoptosis, adhesion, regulation of transcription, and signaling. In the cell lineage marker gene sets, we also included selected genes (supplementary table IA). 4 
Gene pairs for discrimination of HSC, E-B, and pro-B stages, and E-B gene expression profile
Seventy-two genes were selected because they characterized differences between the three first stages (one stage vs rest or one stage vs next stage), had at least a 2-fold change, and were coding for membrane proteins (selected by GO terms) or because they were of particular interest. All pairs of these 72 genes were examined to determine whether the expression levels of some of these gene pairs discriminated between the three stages. To test whether sample groups could be separated given the expression of two genes, we used the scoring function:
The online version of this article contains supplemental material. 
Results

Differential gene expression in HSC, E-B, pro-B, pre-B, and IM-B cell populations
The objective of this study was to perform gene expression profiling of the earliest developmental stages of human B cell differentiation. RNA was extracted from 1 ϫ 10 4 -8 ϫ 10 4 cells of each of the five populations from normal adult human BM: CD34
pre-B cells, and CD34 Ϫ CD10 ϩ CD19 ϩ IgM ϩ IM-B cells, followed by linear RNA amplification and hybridization to Lymphochip cDNA microarrays (Fig. 1A) . The mRNA expression of the genes encoding the selection markers corresponded closely to the expression of the respective proteins, confirming the validity of the approach (Fig. 1B) . Furthermore, expression of 758 genes differed significantly between two subsequent stages of differentiation (Ն2-fold change, FDR 10%). Hierarchical clustering of these genes revealed a pattern that clearly separated the five consecutive cell populations (Fig. 1C) . Indeed, each population displayed a distinct gene expression profile that was remarkably consistent among the individual donors (n ϭ 6). Furthermore, there was a stepwise change in the gene expression pattern from HSC throughout the other developmental stages. A total of 191, 189, 234, and 363 genes changed in the HSC to E-B, E-B to pro-B, pro-B to pre-B, and pre-B to IM-B cell transitions, respectively (total gene list in supplementary table IB) .
Lineage-associated markers
The expression of genes known to participate in B cell differentiation and activation (B cell-associated markers), illustrated the shift in gene expression during B lymphopoiesis (Fig. 2 , B cell markers). As expected, several B lineage-associated genes, including CD19, CD24, CD79B, and VPREB3, showed highest expression levels from the pro-B stage and through the subsequent stages (cluster IV). Interestingly, ADA, DNTT (TdT), and the Ig recombination genes RAG1 and RAG2 showed increased expression levels already in the CD34 ϩ CD38 ϩ CD10 ϩ CD19 Ϫ E-B population (4.5-, 26.1-, 7.3-, and 5.6-fold increase, respectively, compared with the expression levels in HSC), together with HMGB1, HMGB2, and EZH2, suggesting that the rearrangement machinery is activated in CD19-negative cells (cluster II). Additionally, TCF3 (E2A), EBF, and PAX5, which are of crucial importance for B cell development and function, were expressed at higher levels in E-B vs HSC (1.7-, 3.5-, and 8.0-fold increase, respectively), and were further increased in the E-B to pro-B transition (2.9-, 1.9-, and 4.4-fold, respectively; Figs. 2 (cluster IV) and 3B, and supplementary table IB). As expected, genes known to be involved in immune responses and Ag binding, including HLAs, TAP2, IGHM, CD83, CD86, BLR1, and BTG1, showed the highest expression levels in the pre-B and IM-B populations (cluster III).
The E-B population also expressed several genes encoding T or NK lineage-associated markers, including CD2, SELL (CD62L), CD99, CD244, and NOTCH1 (Fig. 2 , T/NK cell markers). Moreover, NOTCH1, which is crucial for T lineage commitment and development, was expressed in HSC, E-B and pro-B cells, but was down-regulated in later stages. In contrast, GATA3 which also is important for T lineage commitment was down-regulated in the HSC to E-B transition. Interestingly, E-B cells had higher expression levels of myeloid-associated markers MPO, PECAM1, and TNFSF13B, than HSC and pro-B cells (Fig. 2 , myeloid cell markers). 
CD38
Ϫ hemopoietic stem cells (HSC), CD34
precursor B cells (pre-B), and CD34
B, Expression of the genes encoding the selection markers confirmed the validity of the approach. C, Hierarchical clustering of the 758 genes that differed significantly between two subsequent stages of differentiation (Ն2-fold change, FDR 10%). Total RNA was extracted from the purified cell populations, amplified, and hybridized to Lymphochip cDNA microarrays. Independent experiments from six different donors were performed for each cell population. Color changes within a row indicate expression levels relative to the average of the sample population.
Gene expression patterns related to function
To further investigate the functional assignment of the differentially expressed genes, we used the proliferation signature (18) , or created gene sets based on information from GO (details in Materials and Methods and supplementary table IA). The proliferation signature included different cell cycle control genes, cell cycle checkpoint genes, and genes involved in DNA synthesis and replication. Interestingly, this signature divided the populations largely in two groups: the HSC and IM population showed low expression of virtually all genes in this signature (Fig. 3A , proliferation signature). In contrast, the pro-B and pre-B populations comprised high expression levels of nearly all the proliferationassociated genes, in agreement with the clonal expansion and rapid proliferation which follow successful rearrangement of the H and L chains. Interestingly, the proliferation signature suggested that the E-B population was not as quiescent as HSC cells. Thirty proliferation-associated genes were increased Ͼ2-fold in the HSC to E-B transition, including several genes involved in S phase, such as CKEK1, TOP2A, UHRF1, PCNA, BZW1, and ILF3, and genes involved in the G 2 /M phase transition (KIF11, KIF14, and BUB1) (Fig. 3B) . These results corresponded well with the findings that 13 Ϯ 2% of E-B cells were in S/G 2 /M phase of cell cycle, compared with 0.4 Ϯ 0.2% and 30 Ϯ 2% of HSC and pro-B cells, respectively (n ϭ 4, data not shown). The high fraction of quiescent cells in the HSC population is in accordance with the finding of others (22, 23) , and a progressive reduction in the percentage of G 0 cells during differentiation has also been detected in mice (24) .
The apoptosis gene set included 38 differentially expressed genes which could be separated in three main clusters (Fig. 3A , apoptosis gene set). Of note, genes with highest mRNA expression levels in HSC and particularly in E-B, included the antiapoptotic gene BCL2 in addition to TNFSF13B (encoding the cytokine BAFF), but also the proapoptotic gene DAPK1 (cluster II). Several antiapoptotic genes such as BIRC5 (survivine), MYBL2 (B-myb), and FAIM, as well as suppressor of cytokine signaling 2 showed highest expression levels in pro-B and pre-B cells (cluster III). Finally, genes with highest expression levels in IM-B cells and partially also in pre-B cells, included several genes involved in induction of apoptosis like BTG1, HRK, TRAF5, STK17B, TN-FRSF21, and BIK (cluster I). Taken together, the populations with highest similarity regarding expression of the genes in the apoptosis gene set turned out to be the HSC and E-B populations.
The adhesion gene set generated four main clusters which clearly illustrated the shift in expression of cell-cell and cell-matrix molecules as the cells mature (Fig. 3A, adhesion gene set) . Genes with high expression in HSC and E-B and low expression in the next three populations included ITGB2, CD44, and SELL (CD62L) (cluster I), while CD34, CDH2 (N-cadherin), CD99, and ITGA6 showed high expression in the first three populations and were down-regulated in the pre-B and IM-B cell populations (cluster II). CD44 and CDH2 have recently been implicated to play a role in interaction with the stem cell niche (25, 26) . Interestingly, CTNNA1 (␣-catenin), ICAM3, and SELP (P-selectin) are the only genes in the gene set that were significantly down-regulated in the HSC to E-B transition, whereas all others were abundantly expressed also in E-B cells (Fig. 3B) . As the cells have rearranged the Ig H (pre-B) and L chains (IM-B), and the stroma dependency is declining (27) , a new set of adhesion genes were up-regulated, including CD72, CD9, and VCAM1 (cluster IV).
Totally, 111 genes associated with transcription regulation were differentially expressed in the five populations (Fig. 3A , transcription gene set). Transcription factors with high mRNA expression in HSC and partly also in E-B, which were down-regulated in the next three consecutive populations, included homeobox genes known to play a crucial role in normal development like HOXB6, HOXB2, and MEIS1, and genes important for the self-renewal potential such as STAT5A (cluster I). Genes with high expression levels in the first three populations (HSC, E-B, and pro-B cells), and then down-regulated in the pre-B and IM-B populations included TIEG, XBP1, ERG, and TCF7L2 (cluster III). As earlier described, the essential transcription factors EBF, TCF3, PAX5, and LEF1 were up-regulated in HSC to E-B and in E-B to pro-B transitions and continued to be high during the next differentiation steps (cluster VI). Interestingly, several other transcription factors showed similar expression patterns including MEF2A, ZHX2, ZCCHC7, DMTF1, NR3C1, FOXO1A, BACH2, and RB1. Cluster V consisted of genes with high expression levels in 1) E-B and pro-B or 2) pro-B and pre-B. The genes up-regulated in E-B and pro-B cells included BCL11A, which is essential for normal lymphopoiesis (28) (cluster Va). Among the genes up-regulated in pro-B and pre-B cells were transcription factors known to be involved in regulation of proliferation or differentiation including MYBL2, FOXM1, GFI1 and TCF19 (Cluster Vb). Finally, several of the transcription factors with high expression levels in the pre-B and IM-B cells included the transcription factors IRF4, ICSBP1 (IRF8), NFATC4 and VDR, (cluster IV). Interestingly, several of the transcription factors that were expressed during the earliest stages of B cell development were also found to be highly expressed in germinal center (GC) cells (GC B cells or CD19 ϩ peripheral blood B cells, data not shown), including XBP1, BACH2, HMGB2, EZH2, MCM2, MCM7, TCF19, FOXM1, NR3C1, RB1, UHRF1, E2F1, and SMARCA4.
Finally, 127 genes coupled to intracellular signaling generated six clusters (Fig. 3A, signaling gene set) . Genes with low expression in HSC, E-B, and pro-B, but that were highly up-regulated in pre-B and IM-B cells, included the chemokine and cytokine receptors CXCR4 and IL4R, and several kinases including FGR, TRAF5, and LYN (cluster II). Interestingly, the TNF family members, TNFSR13B (BLyS/BAFF) and TNFSF4 (OX40L), were down-regulated in pre-B and IM-B cells (cluster IV). Additionally, adaptor proteins and kinases were represented in this cluster, including LCP2 (SLP76), FYN, MAP4K3 and MAPKAPK3. Thus, the mRNA levels of LYN and FYN, which are important in (pre-) BCR signaling, were inversely expressed in the five populations. Finally, genes included in cluster VI were up-regulated in pro-B and pre-B cells, and partly in E-B cells. In addition to genes involved in cell cycle regulation, this cluster also included BLNK (SLP65), an important downstream mediator of (pre-) BCR signaling.
E-B gene expression profile
To characterize the earliest steps in B cell development in further detail, we next compared genes differentially expressed in E-B compared with the neighbor populations HSC and pro-B cells (2-fold change, 30% FDR), giving a list of 22 genes which constituted the E-B gene expression profile (Table II) . Among these genes, 18 showed higher and 4 showed lower expression levels in E-B compared with the HSC and pro-B populations. Interestingly, IGJ (J chain) was the gene showing the highest differential expression in the E-B population with a 9.4-fold increase compared with the two neighboring populations. Additionally, the other up-regulated genes included the antiapoptotic gene BCL2, IL1RAP (essential signal transducing component of the functional IL-1R), CYBB (a subunit of cytochrome b), the MHC class II regulatory factor RFX1, the inhibitory smad MADH7, S100A8 (a calcium-binding S100 protein involved in the regulation of cell cycle progression and differentiation) and MPO (a heme protein synthesized during myeloid differentiation).
Characterization of HSC, E-B, and pro-B cells by gene pairs
A gene pair class separation test was performed to identify combinations of markers that could better discriminate the E-B population from HSC and pro-B. Totally, 2556 gene pairs were tested and examined, resulting in 68 gene pairs with a score above 10 that were denoted very good discriminators. The gene pairs DNTT/ SELL, CD38/CD44, and IL1RAP/CD44 were all very good discriminators for the three populations with score 12.1, 10.9, and 26.8, respectively (Fig. 4 and Table III) .
Confirmation of the differential expression of selected genes by FACS analysis
Among the genes identified in the E-B gene expression profile, we selected a set of genes to be examined at the protein level based on feasibility in FACS analyses. In addition, we included receptors known to be involved during B lymphopoiesis, like CD127 (IL-7R␣) and CXCR4. Thus, CD34
ϩ cells were stained with Abs to identify the HSC, E-B, and pro-B populations, in addition to Abs to the selected proteins. Overall, there were good correlations between mRNA and protein levels in the three populations (Fig. 5) . E-B cells demonstrated a strong and relatively homogenous expression of TdT protein and most of these cells also expressed IL-1RAcP (IL1RAP), Bcl-2, CD127, and CXCR4. Moreover, we detected a weak expression of J chain and CD2 in E-B, while HSC and pro B cells did not express detectable levels. The expression level of CD62L (SELL) was relatively homogeneous and strong in E-B cells, in contrast to a weaker and more heterogeneous expression in HSC and pro-B cells, respectively. Despite higher MPO mRNA levels in E-B cells than in HSC and pro-B cells, we did not observe detectable levels of MPO protein in these cells (Fig. 5, B and C) .
Protein expression of selected gene pairs, including CD38 and CD44, were also analyzed at the single-cell level by FACS analysis. As the protein expression of several of these gene pairs was relatively heterogeneous, particularly in pro-B cells, we obtained a less good separation of these three populations by FACS analysis compared with use of (average) mRNA levels (data not shown).
Discussion
In this study, we have characterized early human B cell development by gene expression profiling of five consecutive populations in adult BM: HSC, E-B, pro-B, pre-B, and IM-B cells using RNA amplification and Lymphochip cDNA microarrays. Gene sets were used to characterize the different populations in further detail. As the earliest stages in human B lymphopoiesis are not clearly defined, we particularly focused on the characterization of the E-B population and the changes in gene expression during the transition from HSC to E-B and from E-B to pro-B cells.
In the present study, we have defined the population CD34 ϩ CD38 ϩ CD10 ϩ CD19 Ϫ as E-B cells. Recent data suggest that this population encompasses several subpopulations (1). In humans, most investigators have identified CLP as
Ϫ cells expressing CD127 (IL-7R␣), were found to be biased toward the B lineage (30) . We found that the majority of CD34 ϩ CD10 ϩ CD19 Ϫ E-B cells expressed CD127 (77 Ϯ 1%), while only a small fraction coexpressed CD7 (3 Ϯ 1%, data not shown). This is in line with other data, which also indicated that CD34 ϩ CD7 ϩ cells are biased to T lineage development (31) . Interestingly, we found that the T/NK cell-associated gene CD2 was specifically expressed in E-B cells both at the mRNA and the protein level. CD2 expression has previously been detected on normal and neoplastic B progenitors (32) , but the striking expression of CD2 on CD34 ϩ CD38 ϩ CD10 ϩ CD19 Ϫ cells has not been previously recognized. In addition, other T/NK-associated genes were also expressed in E-B cells, including IL1RAP, SELL, CD244, CD99, and NOTCH1. Furthermore, E-B cells expressed mRNA for the myeloid-associated genes MPO, PECAM1, and TNFSF13B, although MPO protein expression could not be detected. Taken together, these data suggest that the E-B population might contain cells with multilineage potential. Of note, Rumfelt et al. (33) recently demonstrated that murine CD19 Ϫ B cell precursor populations revealed considerable lineage plasticity and could be divided into three subpopulations, including multilineage progenitor cells, CLP cells which possessed lymphoid and myeloid potential (MLP), and pre-pro-B cells which possessed B/T potential. Investigations to further subdivide human CD34 ϩ cells on the basis of CD2, CD10, CD22, CD62L, CD244, CXCR4, and CD127 expression, in combination with functional studies to explore the lineage plasticity, might be of value for better characterization of different E-B lineage populations in humans.
How early the initiation of VDJ rearrangement in B lineage cells starts is still debated and has been a focus in recent studies. We found that the E-B population had turned on transcription of several genes encoding proteins involved in gene rearrangement, including RAG1, RAG2, DNTT (TdT), and ADA, indicating that the recombinase machinery is initiated before expression of CD19. This is in line with other studies, which also found high expression of TdT in human CD34 ϩ CD19 Ϫ CD10 ϩ lin Ϫ cells (4) 
, extracellular proteins in A and intracellular proteins in B. Each protein was verified at least twice. C, The mRNA expression of the selected genes. All the selected genes differed significantly between the different populations (Ն2-fold change, FDR 10%), except for CD127 which did not change significantly at the mRNA level.
precedes CD10 and CD19 expression and that these cells have DJ H rearrangement and faintly express PAX5 (35, 36) .
Crucial transcription factors involved in E-B lymphopoiesis, including E2A, EBF, PAX5, BCL11A, and LEF1, were also turned on in the HSC to E-B transition, and showed a further increase in the pro-B population. This is in agreement with recent findings at the single-cell level in mice where E2A was found to be expressed in MLP, whereas EBF and PAX5 were expressed in the progression from CLP to pre-pro-B cells (33) . Some genes known to be activated by PAX5 were found to be increased in the E-B population including BLNK (8.4-fold) and CD79A (1.9-fold), whereas another target gene, CD19, was turned on in the pro-B cells. IGJ and XBP1, genes known to be repressed by PAX5, were down-regulated in pro-B and pre-B cells, respectively. The differential effects of PAX5 on various target genes is in line with previous data (37) and is likely due to variable expression and/or activity of transcriptional coregulators interacting with PAX5 at the different stages in B cell development. Of note, we also identified a number of genes encoding transcription factors with expression pattern similar to the described essential factors. EWSR1, ZCCHC7, MEF2A, and NR3C1 showed exactly the same expression pattern as EBF, whereas the expression of ARID5B, ZHX2, DMTF1, FOXO1A, BACH2, ZEP36L1, and RB1 was similar to the expression of E2A and PAX5. Many of these genes have a well-characterized role in cell cycle regulation, whereas little is known regarding other genes, in particular the zinc finger transcription factors ZHX2 and ZCCHC7. Thus, these two transcription factors represent interesting candidates to be further explored regarding a putative role in E-B cell development.
Of note, several of the transcription factors showed a biphasic expression pattern during B cell development. We observed that IRF4 and ICSBP1 (IRF8) showed expression peaks in the pre-B and IM-B cells, respectively. In line with this, double knockout mice (IRF4 Ϫ/Ϫ IRF8 Ϫ/Ϫ ) were shown to have a complete block at the pre-B cell stage, demonstrating a crucial role for these factors in the transition from pre-B to IM-B cells (38) . Both genes are down-regulated at later stages until re-expressed in a subpopulation of centrocytes and in plasma cells (39) , where they control class-switch recombination and plasma cell differentiation, respectively (40, 41) . BCL11A also demonstrated a biphasic expression pattern with up-regulation in the E-B and pro-B populations. BCL11A has previously been demonstrated to be essential for lineage commitment of both B and T cells in mice (28) , and is expressed also in GC cells, where it functions as a transcriptional repressor (42, 43) . Interestingly, we identified several other transcription factors with biphasic expression patterns. Most of these factors are known to be important for the cell cycle, RNA transcription, or cell proliferation, but also included factors involved in V(D)J recombination such as HMGB2 and EZH2 (44, 45) . In addition, we observed high expression levels in early stages of B cell development of other transcription factors with known essential roles in GC B cells or plasma cells, including BACH2 and XBP1 (46, 47) . However, there is no evidence for a functional role for these factors in E-B cell progenitors. Taken together, the biphasic expression of several transcription factors during B cell differentiation suggest the use of similar transcriptional networks in E-B cell stages and in GC and plasma cells.
One of the surprising findings in our study was that IGJ gene (J chain) expression was significantly up-regulated in E-B cells compared with HSC and pro-B cells. The mRNA expression in E-B cells was, however, much lower than in IM-B cells. In line with this, we could detect weak, but distinct, protein expression of J chain in E-B cells, but not in HSC or in pro-B cells (Table   II and Fig. 5 ). The J chain determines the correct assembly of IgA dimers and IgM pentamers (48) , and accordingly shows a strong increase during the last stages of B cell activation (49) . In line with our data, J-chain mRNA expression has previously been detected in B cell lines representing progenitors and also in primary cells including E-B progenitors (CD34 ϩ CD19 Ϫ ), pro-B cells, and in early fetal thymocytes (50 -52) . The transcriptional regulation of J-chain expression has been well-studied in mice (53, 54) , and myocyte enhancer factor-2 (MEF2) is one of the known positive regulators of IGJ gene expression. Of note, we found that MEF2A was highly up-regulated in E-B cells, suggesting that the increased MEF2A levels could contribute to J-chain expression in E-B cells. Pax5, a negative regulator of IGJ, was slightly up-regulated in E-B cells, and showed a further increase in the E-B/pro-B transition. It has been hypothesized that high levels of Pax5 prevent IGJ expression during B cell development until Pax5 is down-regulated at the plasma cell stage (53, 54) . Thus, the transient IGJ expression observed at the E-B stage could be due to high expression of MEF2A, preceding high levels of Pax5 in pro B cells. The transient expression of J chain in early lymphoid progenitors, before Ig expression, is intriguing, but so far there is no evidence for a functional role for J chain in early progenitors.
Identification and characterization of the gene expression in normal precursor B cell subsets are valuable for the study of malignant B lineage cells, and can give a more precise reference for the cellular origin of precursor B cell acute lymphoblastic leukemia (ALL). ALL is a heterogeneous disease with a number of genetically distinct leukemia subtypes, and can arise from any stage of development, including primitive cells with multilineage potential. Gene expression profiling (55) (56) (57) , and single nucleotide polymorphism array analysis have provided new insights into the underlying biology of ALL subtypes (58) . Interestingly, Mullighan et al. (59) recently used single nucleotide polymorphism arrays to detect genetic alterations in leukemic cells from 242 ALL patients. PAX5 turned out to be the most frequently mutated gene, giving reduced levels of PAX5 protein or generated hypomorphic alleles. Furthermore, deletions were also detected in TCF3, LEF1, IKZF1, and IKZF3, suggesting that direct disruption of pathways controlling B cell development contributes to B-ALL pathogenesis. Hence, comparison of gene expression profiles of normal and neoplastic B cell progenitors may identify genes involved in the oncogenic transformation and gene products of potential prognostic and therapeutic relevance.
